ASHLEY PEACE: Open Payments
NPI 1043622558 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$15,844 in 164 payments from 19 companies in 2025. Trend: 2023 $1,003 · 2024 $8,743 · 2025 $15,844
Speaker / faculty: $11,785Food & beverage: $3,157Travel & lodging: $819Education: $84
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 27 | $11,020 |
| Gilead Sciences, Inc. | 22 | $2,747 |
| ABBVIE INC. | 45 | $676 |
| Janssen Biotech, Inc. | 9 | $232 |
| Ipsen Biopharmaceuticals, Inc | 8 | $188 |
| Ardelyx, Inc. | 11 | $174 |
| PFIZER INC. | 7 | $142 |
| Regeneron Healthcare Solutions, Inc. | 5 | $141 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $107 |
| Phathom Pharmaceuticals, Inc. | 9 | $98 |
Products named: REZDIFFRA, Epclusa, Veklury, RINVOQ, TREMFYA, IQIRVO, IBSRELA, DUPIXENT.
Industry payments across AL — which companies pay providers there.
